å§Ñô¶«·½Ò½ÔºÄпÆÖÎÔçйºÜ²»´í(å§Ñô¶«·½¸¾¿Æ¼¼Êõ°²È«·ÅÐÄ) (½ñÈÕ¸üÐÂÖÐ)

NEW YORK (AP) ¡ª A 75-foot Norway spruce has arrived at New York City¡¯s Rockefeller Center to serve as one of the world¡¯s most famous Christmas trees. The tree was trucked in Saturday morning and lifted into place by a crane. The tree will be decorated over the coming weeks. It was donated by Al Dick of Daddy Al¡¯s General Store in Oneonta in central New York. NBC says it's broadcasting the tree-lighting at 7 p.m. Dec. 2. No in-person spectators will be allowed this year because of the coronavirus pandemic. The pandemic has spurred the cancellation of other New York holiday customs including the Radio City Christmas Spectacular. 642

Nevada Highway Patrol has found the driver who hit one of their patrol cars on Monday.It happened around 5:03 p.m. local time Monday. A trooper was conducting a traffic stop on U.S. 95 northbound near Summerlin Parkway. Both vehicles were stopped on the right shoulder when another vehicle disregarded the Move Over Law and hit the trooper's vehicle.The collision resulted in the door being almost torn off. The driver of the other vehicle kept going.After the hit-and-run driver was found Tuesday, the person was ticketed but not arrested. She was issued citations for driving without a valid license, hit-and-run property damage and failure to stop and render aid, all misdemeanors.Fortunately, the trooper was not injured.NHP released body-camera video of the incident.  801

Next March, the monthly subscription price of Disney+ will increase by in the United States.During its annual Investors Day, Disney announced that beginning March 26, 2021, the monthly subscription price would cost .99. Its yearly subscription would increase by to .99.The Disney Bundle that includes Disney+, Hulu with ads, and ESPN+ would increase by to .99 per month, the company announced.The company also announced that in Europe, Disney+ would go from €6.99 to €8.99 per month, alongside the Star rollout, which debuts Feb. 23.The news comes after Netflix announced in October that they would raise the price on its standard and premium plans for its US subscribers. 698

North Korea has agreed to refrain from conducting nuclear and missile tests while engaging in dialogue with South Korea, Seoul's national security chief Chung Eui-yong said Tuesday after returning from a meeting with North Korean leader Kim Jong Un.Chung added that Pyongyang also expressed willingness to talk to the United States "in an open-ended dialogue to discuss the issue of denuclearization and to normalize relations with North Korea."Chung said that as part of the dialogue, the two Koreas would hold a summit next month, the first of its kind in more than a decade.The last inter-Korean summit was in 2007, when South Korean President Roh Moo-hyun met Kim's father, late North Korean leader Kim Jong Il.The meeting will be held at the Panmunjom Peace House on the South Korean side of the demilitarized zone that divides the two countries, Chung said.Pyongyang and Seoul will also open a communication hotline that will enable Kim and South Korean President Moon Jae-in to speak directly.Moon sent Chung and four other top government officials to Pyongyang Monday, when they met with Kim and some of his top aides.It's believed to be the first time the young North Korean leader has ever met with any officials from South Korea since taking power in 2011.Developing story - more to come  1312

NEW YORK ¡ª An influential scientific panel on Tuesday voted to recommend to the CDC that when a COVID-19 vaccine becomes available, both front line health care workers and residents in long-term care facilities should be prioritized first. The Advisory Committee on Immunization Practices voted 14-1 in favor of adopting the following recommendation: When a COVID-19 vaccine is authorized by FDA and recommended by ACIP, vaccination in the initial phase of the COVID-19 vaccination program (Phase 1a) should be offered to both 1) health care personnel and 2) residents of long-term care facilities.Watch the meeting live here."About one (American) dies every minute from COVID-19. During this ACIP meeting, about 120 people will die," Dr. Beth Bell said during initial remarks at the beginning of the virtual meeting Tuesday.The ACIP met Tuesday afternoon in an open-to-the-public, virtual meeting to vote on the proposal that gives priority to health care workers and patients in nursing homes and other long-term care facilities. The two groups together represent around 23 million Americans out of a population of about 330 million; about 21 million in health care professions and less than 3 million adults living in long-term care facilities.Current estimates project around 40 million doses combined available by the end of 2020. And each vaccine product requires two doses.The CDC said Tuesday they expect 5-to-10 million doses available each week after a vaccine is authorized by the FDA. They say these numbers necessitate the need for sub-group prioritizing, since not all health care workers or long-term care facilities can be vaccinated at once. Another consideration the panel discussed is not having an entire unit or group get vaccinated at once; if there are side effects like fatigue or other symptoms that necessitates taking a day or two off, this could leave a unit critically short-staffed. During Tuesday's presentation, Dr. Kathleen Dooling talked about statistics from COVID-19 patients in the US and how it lead to health care workers and long-term facility staff and patients to be at the top of the vaccine list. Long-term care facilities are responsible for six percent of COVID-19 cases and 40 percent of COVID-19 deaths in this country, she said. Later this month, the Food and Drug Administration will consider approval of two vaccines made by Pfizer and Moderna. The panel meeting Tuesday said they hope to learn more about the safety and effectiveness of the vaccines as more information is released by the FDA.Dr. Dooling said one of the questions they hope to ask about the Phase 3 trial data of both Pfizer and Moderna is how effective one dose of the vaccine has shown to be. They will also be taking a deeper look at the age groups of those included in the trial, and the efficacy of the vaccines on older people. Some of the comments during the public comment section referenced the lack of transparency released at this time about the vaccines and the panel trying to make vaccination decisions without it. However, the panel, while voting, expressed faith in the FDA's process of approving the vaccine as safe for all Americans. Once vaccines are given, the CDC and FDA will be asking all health care providers and facilities to use the existing Vaccine Adverse Event Reporting System, VAERS, to monitor any side effects and adverse reactions to the COVID-19 vaccines. The advisory panel will meet again at some point to decide who should be next in line. Among the possibilities: teachers, police, firefighters and workers in other essential fields such as food production and transportation; the elderly; and people with underlying medical conditions.Experts say the vaccine will probably not become widely available in the U.S. until the spring.ACIP is a 15-member panel of outside scientific experts, created in 1964, that makes recommendations to the director of the Centers for Disease Control and Prevention, who almost always approves them. Childhood vaccine schedules are one example of the work of this group. The recommendations are not binding, but for decades they have been widely heeded by doctors, and they have determined the scope and funding of U.S. vaccination programs.It will be up to state authorities whether to follow the guidance. It will also be left to them to make further, more detailed decisions if necessary ¡ª for example, whether to put emergency room doctors and nurses ahead of other health care workers if vaccine supplies are low. 4517

À´Ô´£º×ÊÑô±¨